Esperion Therapeutics
ESPR
#6142
Rank
A$1.37 B
Marketcap
A$5.79
Share price
-3.96%
Change (1 day)
61.69%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: A$1.37 Billion

As of December 2025 Esperion Therapeutics has a market cap of A$1.37 Billion. This makes Esperion Therapeutics the world's 6142th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025A$1.37 B90.13%
2024A$0.72 B44.72%
2023A$0.49 B-26.02%
2022A$0.67 B60.61%
2021A$0.42 B-52.07%
2020A$0.87 B-62.58%
2019A$2.34 B33.71%
2018A$1.75 B-20.72%
2017A$2.20 B463.99%
2016A$0.39 B-43.06%
2015A$0.68 B-31.56%
2014A$1.00 B325.39%
2013A$0.23 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Esperion Therapeutics was reported to be:

A$1.44 Billion
by Nasdaq info icon info icon
A$1.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
A$4.91 B 257.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$17.53 B 1,176.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$211.18 B 15,279.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$124.23 B 8,947.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$6.56 B 377.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$0.65 B-52.20%๐Ÿ‡บ๐Ÿ‡ธ USA